439 results on '"Walder, Ken"'
Search Results
2. Network-based drug repurposing for schizophrenia
3. Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity
4. Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
5. CaMKK2 as an emerging treatment target for bipolar disorder
6. Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
7. Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder
8. Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity
9. A plasma protein signature associated with cognitive function in men without severe cognitive impairment
10. The small leucine-rich proteoglycan, biglycan, is highly expressed in adipose tissue of Psammomys obesus and is associated with obesity and type 2 diabetes
11. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis
12. The role of metformin as a treatment for neuropsychiatric illness
13. Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions
14. Common effects of bipolar disorder medications on expression quantitative trait loci genes
15. Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia
16. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders
17. Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial
18. Diet and depression: future needs to unlock the potential
19. The lipid paradox in neuroprogressive disorders: Causes and consequences
20. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
21. Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity
22. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
23. Diet and depression: exploring the biological mechanisms of action
24. Recombinant Balsamin induces apoptosis in liver and breast cancer cells via cell cycle arrest and regulation of apoptotic pathways
25. The compensatory antioxidant response system with a focus on neuroprogressive disorders
26. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders
27. Modulation of high fat diet-induced microbiome changes, but not behaviour, by minocycline
28. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis
29. Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression
30. The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases
31. Prevalence of BFDV in wild breeding Platycercus elegans
32. The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications
33. Species, sex and geographic variation in chlamydial prevalence in abundant wild Australian parrots
34. Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
35. A model of the mitochondrial basis of bipolar disorder
36. Seasonal fluctuation of beak and feather disease virus (BFDV) infection in wild Crimson Rosellas (Platycercus elegans)
37. Impact of Mood Disorder History and Bone Health on Cognitive Function Among Men Without Dementia.
38. Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents
39. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance.
40. Wireless Optogenetics: An Exploration of Portable Microdevices for Small Animal Photostimulation
41. Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome
42. The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease
43. Balsamin induces apoptosis in breast cancer cells via DNA fragmentation and cell cycle arrest
44. Phylogenetic analysis of beak and feather disease virus across a host ring-species complex
45. Psammomys obesus: a Natural Diet-Controlled Model for Diabetes and Cardiovascular Diseases
46. The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders
47. Functional Analysis of a Type-I Ribosome Inactivating Protein Balsamin from Momordica balsamina with Anti-Microbial and DNase Activity
48. The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability
49. Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis.
50. Metformin is Protective Against the Development of Mood Disorders.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.